Our Mission
To develop accessible, high-performance diagnostic tools that improve detection accuracy and support modern laboratory workflows.
Precision Immunoassays for Modern Laboratories
Advancing Diagnostic Precision
High-performance immunoassays for speed, specificity, and scalability.
Who We Are
About Synvitta Diagnostics
A biotechnology company dedicated to advancing modern diagnostic solutions through precision-engineered biomarker systems.
Founded in Florida, Synvitta combines scientific rigor with practical laboratory integration to develop high-performance immunoassays designed for clinical use and scalable deployment.
Our work focuses on improving analytical specificity, reducing assay time, and enabling seamless transition from singleplex to multiplex platforms.
Our Vision
To become a reference in precision diagnostics through innovative biomarker engineering and scalable assay design.
Technology Platform
One assay architecture. From a single biomarker to a full panel.
Optimized detection chemistries and scalable assay design that stay compatible with standard clinical laboratory workflows — so labs can grow from ELISA to multiplex without changing how they work.
01
Commercial
SynTREP™
Rapid ELISA for total antibodies to Treponema pallidum — Synvitta's first commercial diagnostic solution.
- ~1h15 assay time
- 96-well microplate format
- Serum or plasma
02
Development
SynArray™
Multiplex detection of multiple biomarkers in a single assay while maintaining high analytical performance.
- Panel-level results, one run
- Scalable multiplex architecture
- Clinical-workflow compatible
03
Research
Biomarker Engineering
Synthetic peptide ligands and engineered biomarkers designed to improve diagnostic specificity.
- Precision-engineered ligands
- Higher analytical specificity
- Fuels next-gen panels
Products
Diagnostic Solutions
SynTREP™
Rapid Syphilis ELISA
SynTREP™ is a rapid ELISA assay for detecting total antibodies to Treponema pallidum. Synvitta's first commercial diagnostic solution — built for laboratories that need reliable serological testing with a streamlined workflow.
- ~1h15 assay time
- 96-well ELISA
- Research Use Only
The product video could not be loaded. If you manage this site, run git lfs pull on the server and rebuild the web container.
Technical Information
Key Features
- Rapid assay time (~1h15)
- Detection of total antibodies to Treponema pallidum
- High analytical sensitivity and specificity
- Streamlined ELISA workflow
- Compatible with standard ELISA laboratory equipment
- Designed for scalable laboratory testing
Applications
SynTREP™ can be used for:
- Research laboratories studying syphilis serology
- Assay development and validation studies
- Laboratory research workflows involving treponemal antibody detection
Assay Information
- Assay format
- 96-well ELISA microplate
- Detection method
- Colorimetric ELISA detection
- Assay time
- Approximately 1 hour 15 minutes
- Sample type
- Human serum or plasma
- Technology
- Immunoassay – ELISA format
Regulatory Status
RUOResearch Use Only
This product is intended for research use only and not for use in diagnostic procedures unless otherwise authorized by regulatory authorities.
For pricing, technical information, or partnership inquiries, please contact the Synvitta team.
Company
Scientists, clinicians and operators — building diagnostics that labs can actually run.
Founded in Florida, Synvitta combines scientific rigor with practical laboratory integration to develop accessible, high-performance diagnostic tools that improve detection accuracy and support modern laboratory workflows.
Mitch Glaeser
Co-Founder & Chief Executive Officer
Rainara Almeida
Co-Founder & Chief Scientific Officer
Jefferson Bonavita
Co-Founder & Vice President
Lacey Nieves
Associate Scientist, Diagnostics R&D
William Santos
Production Chemist, SynArray™ Manufacturing
Carlos Ivanski
AI & Data Science Engineer
R&D
Pipeline Development
Expanding Synvitta's diagnostic portfolio through scalable biomarker platforms and multiplex immunoassay technologies designed for clinical laboratory integration.
Neurodegenerative Diseases
Biomarker discovery and assay development focused on enabling early detection and improved monitoring of neurodegenerative diseases.
Autoimmune Diseases
Development of multiplex immunoassay platforms for detection and monitoring of immune-mediated disorders.
Infectious Diseases
Development of high-performance immunoassays designed for rapid, scalable infectious disease diagnostics.
Precision Biomarker Engineering
Development of synthetic peptide ligands and engineered biomarkers designed to improve diagnostic specificity and enable next-generation multiplex diagnostic platforms.
Collaborate With Us
For distribution inquiries, laboratory partnerships, or collaboration opportunities, please contact our team.
Get in Touch